IBDEI06Z ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9127,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,9128,0)
 ;;=J3301^^62^607^7^^^^1
 ;;^UTILITY(U,$J,358.3,9128,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9128,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,9128,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,9129,0)
 ;;=J3396^^62^607^15^^^^1
 ;;^UTILITY(U,$J,358.3,9129,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9129,1,2,0)
 ;;=2^Verteporfin Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,9129,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,9130,0)
 ;;=J9035^^62^607^3^^^^1
 ;;^UTILITY(U,$J,358.3,9130,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9130,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,9130,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,9131,0)
 ;;=J0178^^62^607^1^^^^1
 ;;^UTILITY(U,$J,358.3,9131,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9131,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,9131,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,9132,0)
 ;;=67028^^62^608^1^^^^1
 ;;^UTILITY(U,$J,358.3,9132,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9132,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,9132,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,9133,0)
 ;;=J9035^^62^608^3^^^^1
 ;;^UTILITY(U,$J,358.3,9133,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9133,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,9133,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,9134,0)
 ;;=J2778^^62^608^5^^^^1
 ;;^UTILITY(U,$J,358.3,9134,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9134,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,9134,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,9135,0)
 ;;=J3301^^62^608^4^^^^1
 ;;^UTILITY(U,$J,358.3,9135,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9135,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,9135,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,9136,0)
 ;;=J0178^^62^608^2^^^^1
 ;;^UTILITY(U,$J,358.3,9136,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9136,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,9136,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,9137,0)
 ;;=4450F^^62^609^2^^^^1
 ;;^UTILITY(U,$J,358.3,9137,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9137,1,2,0)
 ;;=2^Self-Care Ed Provided to Pt
 ;;^UTILITY(U,$J,358.3,9137,1,3,0)
 ;;=3^4450F
 ;;^UTILITY(U,$J,358.3,9138,0)
 ;;=4177F^^62^609^3^^^^1
 ;;^UTILITY(U,$J,358.3,9138,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9138,1,2,0)
 ;;=2^Talk Pt/Crgvr Re AREDS
 ;;^UTILITY(U,$J,358.3,9138,1,3,0)
 ;;=3^4177F
 ;;^UTILITY(U,$J,358.3,9139,0)
 ;;=4174F^^62^609^1^^^^1
 ;;^UTILITY(U,$J,358.3,9139,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9139,1,2,0)
 ;;=2^Couns Potent Glauc Impct
 ;;^UTILITY(U,$J,358.3,9139,1,3,0)
 ;;=3^4174F
 ;;^UTILITY(U,$J,358.3,9140,0)
 ;;=373.32^^63^610^48
 ;;^UTILITY(U,$J,358.3,9140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9140,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,9140,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,9140,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,9141,0)
 ;;=373.00^^63^610^4
 ;;^UTILITY(U,$J,358.3,9141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9141,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,9141,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,9141,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,9142,0)
 ;;=373.2^^63^610^7
 ;;^UTILITY(U,$J,358.3,9142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9142,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,9142,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,9142,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,9143,0)
 ;;=374.84^^63^610^29
 ;;^UTILITY(U,$J,358.3,9143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9143,1,3,0)
 ;;=3^Eyelid Cysts
 ;;^UTILITY(U,$J,358.3,9143,1,4,0)
 ;;=4^374.84
 ;;^UTILITY(U,$J,358.3,9143,2)
 ;;=^269119
 ;;^UTILITY(U,$J,358.3,9144,0)
 ;;=374.87^^63^610^31
 ;;^UTILITY(U,$J,358.3,9144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9144,1,3,0)
 ;;=3^Eyelid Dermatochalasis
 ;;^UTILITY(U,$J,358.3,9144,1,4,0)
 ;;=4^374.87
 ;;^UTILITY(U,$J,358.3,9144,2)
 ;;=^269123
 ;;^UTILITY(U,$J,358.3,9145,0)
 ;;=375.15^^63^610^12
 ;;^UTILITY(U,$J,358.3,9145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9145,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,9145,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,9145,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,9146,0)
 ;;=374.01^^63^610^20
 ;;^UTILITY(U,$J,358.3,9146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9146,1,3,0)
 ;;=3^Entropion, Senile
 ;;^UTILITY(U,$J,358.3,9146,1,4,0)
 ;;=4^374.01
 ;;^UTILITY(U,$J,358.3,9146,2)
 ;;=Entropion, Senile^269074
 ;;^UTILITY(U,$J,358.3,9147,0)
 ;;=375.20^^63^610^68
 ;;^UTILITY(U,$J,358.3,9147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9147,1,3,0)
 ;;=3^Lacrimal,Epiphora
 ;;^UTILITY(U,$J,358.3,9147,1,4,0)
 ;;=4^375.20
 ;;^UTILITY(U,$J,358.3,9147,2)
 ;;=Epiphora^269136
 ;;^UTILITY(U,$J,358.3,9148,0)
 ;;=373.11^^63^610^63
 ;;^UTILITY(U,$J,358.3,9148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9148,1,3,0)
 ;;=3^Hordeolum Externum
 ;;^UTILITY(U,$J,358.3,9148,1,4,0)
 ;;=4^373.11
 ;;^UTILITY(U,$J,358.3,9148,2)
 ;;=^58510
 ;;^UTILITY(U,$J,358.3,9149,0)
 ;;=373.12^^63^610^64
 ;;^UTILITY(U,$J,358.3,9149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9149,1,3,0)
 ;;=3^Hordeolum Internum
 ;;^UTILITY(U,$J,358.3,9149,1,4,0)
 ;;=4^373.12
 ;;^UTILITY(U,$J,358.3,9149,2)
 ;;=^58512
 ;;^UTILITY(U,$J,358.3,9150,0)
 ;;=216.1^^63^610^54
 ;;^UTILITY(U,$J,358.3,9150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9150,1,3,0)
 ;;=3^Eyelid/Canthus,Benign Neopl
 ;;^UTILITY(U,$J,358.3,9150,1,4,0)
 ;;=4^216.1
 ;;^UTILITY(U,$J,358.3,9150,2)
 ;;=Neoplasm, Benign of Lid^267630
 ;;^UTILITY(U,$J,358.3,9151,0)
 ;;=374.30^^63^610^43
 ;;^UTILITY(U,$J,358.3,9151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9151,1,3,0)
 ;;=3^Eyelid Ptosis,Unspec
 ;;^UTILITY(U,$J,358.3,9151,1,4,0)
 ;;=4^374.30
 ;;^UTILITY(U,$J,358.3,9151,2)
 ;;=^15283
 ;;^UTILITY(U,$J,358.3,9152,0)
 ;;=375.30^^63^610^9
 ;;^UTILITY(U,$J,358.3,9152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9152,1,3,0)
 ;;=3^Dacryocystitis
 ;;^UTILITY(U,$J,358.3,9152,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,9152,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,9153,0)
 ;;=921.1^^63^610^28
 ;;^UTILITY(U,$J,358.3,9153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9153,1,3,0)
 ;;=3^Eyelid Contusion
 ;;^UTILITY(U,$J,358.3,9153,1,4,0)
 ;;=4^921.1
 ;;^UTILITY(U,$J,358.3,9153,2)
 ;;=^275367
 ;;^UTILITY(U,$J,358.3,9154,0)
 ;;=374.51^^63^610^46
 ;;^UTILITY(U,$J,358.3,9154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9154,1,3,0)
 ;;=3^Eyelid Xanthelasma
 ;;^UTILITY(U,$J,358.3,9154,1,4,0)
 ;;=4^374.51
 ;;^UTILITY(U,$J,358.3,9154,2)
 ;;=^269107
 ;;^UTILITY(U,$J,358.3,9155,0)
 ;;=374.11^^63^610^15
 ;;^UTILITY(U,$J,358.3,9155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9155,1,3,0)
 ;;=3^Ectropion, Senile
 ;;^UTILITY(U,$J,358.3,9155,1,4,0)
 ;;=4^374.11
 ;;^UTILITY(U,$J,358.3,9155,2)
 ;;=Ectropion, Senile^269083
 ;;^UTILITY(U,$J,358.3,9156,0)
 ;;=333.81^^63^610^6
 ;;^UTILITY(U,$J,358.3,9156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9156,1,3,0)
 ;;=3^Blepharospasm
 ;;^UTILITY(U,$J,358.3,9156,1,4,0)
 ;;=4^333.81
 ;;^UTILITY(U,$J,358.3,9156,2)
 ;;=Blepharospasm^15293
 ;;^UTILITY(U,$J,358.3,9157,0)
 ;;=351.8^^63^610^62
 ;;^UTILITY(U,$J,358.3,9157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9157,1,3,0)
 ;;=3^Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,9157,1,4,0)
 ;;=4^351.8
 ;;^UTILITY(U,$J,358.3,9157,2)
 ;;=Hemifacial Spasm^87589
 ;;^UTILITY(U,$J,358.3,9158,0)
 ;;=374.10^^63^610^17
 ;;^UTILITY(U,$J,358.3,9158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9158,1,3,0)
 ;;=3^Ectropion, Unspecified
 ;;^UTILITY(U,$J,358.3,9158,1,4,0)
 ;;=4^374.10
 ;;^UTILITY(U,$J,358.3,9158,2)
 ;;=Ectropion, Unspecified^38326
 ;;^UTILITY(U,$J,358.3,9159,0)
 ;;=374.14^^63^610^13
 ;;^UTILITY(U,$J,358.3,9159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9159,1,3,0)
 ;;=3^Ectropion, Cicatricial
 ;;^UTILITY(U,$J,358.3,9159,1,4,0)
 ;;=4^374.14
 ;;^UTILITY(U,$J,358.3,9159,2)
 ;;=Edctropion, Cicatricial^269089
 ;;^UTILITY(U,$J,358.3,9160,0)
 ;;=374.12^^63^610^14
 ;;^UTILITY(U,$J,358.3,9160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9160,1,3,0)
 ;;=3^Ectropion, Mechanical
 ;;^UTILITY(U,$J,358.3,9160,1,4,0)
 ;;=4^374.12
 ;;^UTILITY(U,$J,358.3,9160,2)
 ;;=Ectropion, Mechanical^269085
 ;;^UTILITY(U,$J,358.3,9161,0)
 ;;=374.13^^63^610^16
 ;;^UTILITY(U,$J,358.3,9161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9161,1,3,0)
 ;;=3^Ectropion, Spastic
 ;;^UTILITY(U,$J,358.3,9161,1,4,0)
 ;;=4^374.13
 ;;^UTILITY(U,$J,358.3,9161,2)
 ;;=Ectropion, Spastic^269087
 ;;^UTILITY(U,$J,358.3,9162,0)
 ;;=374.00^^63^610^22
 ;;^UTILITY(U,$J,358.3,9162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9162,1,3,0)
 ;;=3^Entropion, Unspec
 ;;^UTILITY(U,$J,358.3,9162,1,4,0)
 ;;=4^374.00
 ;;^UTILITY(U,$J,358.3,9162,2)
 ;;=Entropion, Unspec^41016
 ;;^UTILITY(U,$J,358.3,9163,0)
 ;;=374.04^^63^610^18
 ;;^UTILITY(U,$J,358.3,9163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9163,1,3,0)
 ;;=3^Entropion, Cicatricial
 ;;^UTILITY(U,$J,358.3,9163,1,4,0)
 ;;=4^374.04
 ;;^UTILITY(U,$J,358.3,9163,2)
 ;;=Entropion, Cicatricial^269080
 ;;^UTILITY(U,$J,358.3,9164,0)
 ;;=374.02^^63^610^19
 ;;^UTILITY(U,$J,358.3,9164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9164,1,3,0)
 ;;=3^Entropion, Mechanical
 ;;^UTILITY(U,$J,358.3,9164,1,4,0)
 ;;=4^374.02
 ;;^UTILITY(U,$J,358.3,9164,2)
 ;;=Entropion, Mechanical^269076
 ;;^UTILITY(U,$J,358.3,9165,0)
 ;;=374.03^^63^610^21
 ;;^UTILITY(U,$J,358.3,9165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9165,1,3,0)
 ;;=3^Entropion, Spastic
 ;;^UTILITY(U,$J,358.3,9165,1,4,0)
 ;;=4^374.03
 ;;^UTILITY(U,$J,358.3,9165,2)
 ;;=Spastic Entropion^269078
 ;;^UTILITY(U,$J,358.3,9166,0)
 ;;=870.0^^63^610^58
 ;;^UTILITY(U,$J,358.3,9166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9166,1,3,0)
 ;;=3^Eyelid/Periocular Skin Laceration
 ;;^UTILITY(U,$J,358.3,9166,1,4,0)
 ;;=4^870.0
 ;;^UTILITY(U,$J,358.3,9166,2)
 ;;=Laceration, Eyelid^274879
